Director/PDMR Shareholding

RNS Number : 8419X
Creo Medical Group PLC
24 December 2019
 

Creo Medical Group plc

("Creo" or the "Company")

 

Director / PDMR Shareholding

 

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that following Admission of the New Ordinary Shares today, Charles Spicer, Non-Executive Chairman and David Woods, Non-Executive Director, have purchased 13,800 and 25,000 Ordinary Shares respectively in the Fundraising, at the Issue Price of 180 pence per Ordinary Share. Following these purchases, Charles Spicer and David Woods hold 93,810 and 25,000 Ordinary Shares respectively.

 

Capitalised terms used, but not defined in this announcement shall have the same meaning as set out in the Circular.

 

The information below, set out in accordance with the requirements of the MAR, provides further detail. 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1.    Charles Spicer

2.    David Woods

2

Reason for the notification

a)

Position/status

1.    Non-Executive Chairman

2.    Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creo Medical Group plc

b)

LEI

213800H188ZDCWWXFA21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.001 each

 

 

Identification code

GB00BZ1BLL44

 

 

b)

Nature of the transaction

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

1. 180p

2. 180p

1.  13,800

2.  25,000

 

 

 

 

 

 

d)

Aggregated information

 

 

 

- Aggregated volume

N/A - single transaction

 

 

- Price

 

 

 

e)

Date of the transaction

24 December 2019

f)

Place of the transaction

London Stock Exchange

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFFLFRLVFIA
UK 100

Latest directors dealings